Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Crovalimab[1] Crovalimab (Crovalimab)[1] Crovalimab (Crovalimab, Crovalimab-akkz) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 48, 62, 109 💬
2CrovalimabProduct Code: RO7112689/F03-10Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-Product Name: CrovalimabProduct Code: RO7112689/F03-01Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-----[1] 109 💬